Salix Coronary Plaque vs Bunkerhill ECG-EF
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if you require a detailed, AI-driven analysis of coronary artery plaque and stenosis directly from CCTA scans. This tool is ideal for near real-time, point-of-care assessment to accurately diagnose coronary artery disease, quantify plaque burden, and identify high-risk plaque features for precise risk stratification.
View Salix Coronary Plaque →Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if you need a rapid, non-invasive, and accessible AI algorithm to screen for reduced left ventricular ejection fraction (LVEF ≤ 40%) using routine 12-lead ECGs. This tool is best suited for early identification of patients at risk for heart failure within existing clinical workflows, particularly when advanced imaging is not immediately available or for broad population screening.
View Bunkerhill ECG-EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | Bunkerhill ECG-EF |
|---|---|---|
| Pricing | Contact for pricing | Contact sales for pricing details. |
| Deployment | Cloud | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | Bunkerhill ECG-EF |
|---|---|---|
| Product Name | Salix Coronary Plaque | Bunkerhill ECG-EF |
| Company | Artrya Limited | BunkerHill Health |
| Description | FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. | FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. |
| Primary Data Input | CCTA scans | Routine 12-lead electrocardiograms (ECGs) |
| Key Diagnostic Focus | Coronary artery plaque and stenosis, coronary artery disease | Reduced left ventricular ejection fraction (LVEF u2264 40%), heart failure risk |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Bunkerhill ECG-EF.